ASSERTIO THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, after Year Five
ASSERTIO THERAPEUTICS, INC. had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $187.58 million as of 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2019-03-11
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $187.58M.
- 2018-09-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $286.81M.
- 2018-06-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $286.81M.
- 2018-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $286.81M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2018-12-31 | $187.58M 10-K · filed 2019-03-11 |
| 2018-09-30 | $286.81M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $286.81M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $286.81M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $286.81M 10-K · filed 2018-03-01 |
| 2017-09-30 | $387.45M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $387.45M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $387.45M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $387.45M 10-K · filed 2017-02-24 |
| 2016-09-30 | $468.26M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $468.26M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $468.26M 10-Q · filed 2016-05-06 |
| 2015-09-30 | $576.14M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $576.14M 10-Q · filed 2015-08-03 |
| 2014-12-31 | $23.40M 10-K · filed 2015-02-26 |